BiotechTV

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: Edward Hodgkin is the Executive Chair of @SynconaLtd's 'Slingshot', a platform that takes early stage science from academic labs that isn't ready to be a company and helps matures it. Full video: biotechtv.com/post/slingshot…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @ResolutionTx is in the clinic with its engineered regenerative macrophage therapy to treat end stage liver disease. Full video: biotechtv.com/post/resolutio…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: With science from @TheCrick, ALTx Therapeutics launched with £12.55m last month to target cancers that rely on the Alternative Lengthening of Telomeres (ALT). Full video: biotechtv.com/post/altx-ther…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @iOnctura is developing its allosteric PI3Kδ for uveal melanoma - an indication that has seen progress but still has much unmet need. Full video: biotechtv.com/post/ionctura-…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @SpurTherapeutx is in a phase 3 for its gene therapy for Gaucher Disease - using a unique construct that allows them to have a lower dose than other gene therapies. Full video: biotechtv.com/post/spur-ther…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @BeaconTx_ has a phase 3 trial scheduled to read this year for its gene therapy for X Linked Retinitis Pigmentosa (XLRP). Full video: biotechtv.com/post/beacon-th…

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @SynconaLtd CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day. Full video: biotechtv.com/post/chris-hol…

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰: @MassBio State of Possible Conference is Thursday, March 26th at the Boston Omni Seaport. It is the premier event of the year for the Massachusetts life sciences industry BiotechTV will be there. See you next week! Register: massbio.org/events/state-o…

𝐀𝐈 𝐍𝐞𝐰𝐬: Checking in with @MenloVentures' Partner @grgyap to get his take on the latest trends in AI in healthcare. Full video: biotechtv.com/post/menlo-ven…

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: @JNJNews's ICOTYDE, a new oral pill for moderate to severe plaque psoriasis was approved by FDA. The approval is the result of over a decade of work on peptide science by its partner @ProtagonistTx. $JNJ $PTGX

𝐎𝐫𝐩𝐡𝐚𝐧 𝐃𝐫𝐮𝐠 𝐑𝐞𝐩𝐨𝐫𝐭: @evaluatepharma's Orphan Drug report is FREE to download now, packed with analysis and data on the booming rare disease space. DOWNLOAD the FREE report here: evaluate.com/thought-leader…

𝐀𝐈 𝐍𝐞𝐰𝐬: Nvidia strikes again, this time extending its partnership with Roche to supply chips to the drugmaker to create the largest supercomputer in the pharma industry. $NVDA

𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: The clock is already ticking on the patent life of Ozempic. Here are some of the things Novo Nordisk is doing about it. $NVO

𝐁𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞: Bay Area based @goearli, which has raised $105M, is developing 'Cancer-Activated Promoters' that are set off by cancer-specific transcription factors and turn tumor cells into therapy factories. Full video: biotechtv.com/post/earli-mar…

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: GLPs, de novo proteins, China, healthcare economics, new technologies - in this @NYSE video, leaders in healthcare weigh in on the things changing our industry in 2026.

𝐖𝐞𝐞𝐤 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: A recap of biotech biggest movers from the last week. $ACXP $OCGN $ADTX $OLMA Link to video: biotechtv.com/post/biotech-m…

𝐖𝐨𝐦𝐞𝐧'𝐬 𝐇𝐢𝐬𝐭𝐨𝐫𝐲 𝐌𝐨𝐧𝐭𝐡: Why it is important to fund basic research of women's health, and the biotech companies that are betting on it.

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡: @NYSE asked the sharpest minds in healthcare about the future of their industry, here’s what they had to say:

𝐁𝐚𝐫𝐜𝐥𝐚𝐲𝐬 𝐌𝐢𝐚𝐦𝐢: @MannKindCorp CEO Michael Castagna shares an update on the company, including a recent $360M acquisition, and two regulatory reviews at FDA that have decision dates over the coming months. $MNKD Full video: biotechtv.com/post/mannkind-…

𝐁𝐚𝐫𝐜𝐥𝐚𝐲𝐬 𝐌𝐢𝐚𝐦𝐢: Barclays' Senior Biotech Analyst Etzer Darout shares his take on biotech and discusses companies he covers that have been in the news. $ABVX $CRVS $IOVA $LEGN $TERN Full video: biotechtv.com/post/etzer-dar…